Paper11054705
Time course of degenerative alterations in nigral dopaminergic neurons following a 6-hydroxydopamine lesion.
Zuch CL and 5 others. J Comp Neurol, 2000. Cited by 111 papers, by iCite.
Cite this record
ConductScience Library. Time course of degenerative alterations in nigral dopaminergic neurons following a 6-hydroxydopamine lesion. Papers, record 11054705. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11054705
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Nerve Degeneration | Major topic |
| Oxidopamine | Major topic |
| Substantia Nigra | Major topic |
| Sympatholytics | Major topic |
| Animals | |
| Cell Death | |
| Dopamine | |
| Fluorescent Dyes | |
| Immunohistochemistry | |
| In Situ Nick-End Labeling | |
| Longitudinal Studies | |
| Male | |
| Neurons | |
| Parkinsonian Disorders | |
| Rats | |
| Rats, Sprague-Dawley | |
| Tyrosine 3-Monooxygenase |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| AG12122 | NIA NIH HHS | United States | R01AG012122 | PubMed and NIH | NIH RePORTER |
| AG15239 | NIA NIH HHS | United States | R01AG015239 | PubMed and NIH | NIH RePORTER |
| NS10851 | NINDS NIH HHS | United States | PubMed | PubMed |
Cited by46
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 111 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42964833 | A longitudinal study of rotenone-induced Parkinsonism in mice. | iScience | 2026 | https://conductscience.org/library/papers/42964833 | PubMed |
| 41509265 | Parkinsonism Reversal and Dopaminergic Resilience: Lessons from a Rotenone-induced Parkinson's Disease Model. | bioRxiv | 2025 | https://conductscience.org/library/papers/41509265 | PubMed |
| 40969759 | Golexanolone affords sustained microglia and astrocytes activation improvement in a rat model of Parkinson's disease. | Front Immunol | 2025 | https://conductscience.org/library/papers/40969759 | PubMed |
| 40429620 | Olfactory Dysfunction in a Novel Model of Prodromal Parkinson's Disease in Adult Zebrafish. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40429620 | PubMed |
| 38671193 | Insomnia-related rodent models in drug discovery. | Acta Pharmacol Sin | 2024 | https://conductscience.org/library/papers/38671193 | PubMed |
| 37555005 | CDNF and MANF in the brain dopamine system and their potential as treatment for Parkinson's disease. | Front Psychiatry | 2023 | https://conductscience.org/library/papers/37555005 | PubMed |
| 37542151 | CRISPR/sgRNA-directed synergistic activation mediator (SAM) as a therapeutic tool for Parkinson´s disease. | Gene Ther | 2024 | https://conductscience.org/library/papers/37542151 | PubMed |
| 35000153 | Inhibition of TRPM2 by AG490 Is Neuroprotective in a Parkinson's Disease Animal Model. | Mol Neurobiol | 2022 | https://conductscience.org/library/papers/35000153 | PubMed |
| 32602622 | Retracted: Allopregnanolone restores the tyrosine hydroxylase-positive neurons and motor performance in a 6-OHDA-injected mouse model. | CNS Neurosci Ther | 2020 | https://conductscience.org/library/papers/32602622 | PubMed |
| 32394056 | Perillyl Alcohol Mitigates Behavioural Changes and Limits Cell Death and Mitochondrial Changes in Unilateral 6-OHDA Lesion Model of Parkinson's Disease Through Alleviation of Oxidative Stress. | Neurotox Res | 2020 | https://conductscience.org/library/papers/32394056 | PubMed |
| 32001239 | Docosahexaenoic acid protects motor function and increases dopamine synthesis in a rat model of Parkinson's disease via mechanisms associated with increased protein kinase activity in the striatum. | Neuropharmacology | 2020 | https://conductscience.org/library/papers/32001239 | PubMed |
| 31998078 | Allopregnanolone Modulates GABAAR-Dependent CaMKIIδ3 and BDNF to Protect SH-SY5Y Cells Against 6-OHDA-Induced Damage. | Front Cell Neurosci | 2019 | https://conductscience.org/library/papers/31998078 | PubMed |
| 31911115 | The drug adaptaquin blocks ATF4/CHOP-dependent pro-death Trib3 induction and protects in cellular and mouse models of Parkinson's disease. | Neurobiol Dis | 2020 | https://conductscience.org/library/papers/31911115 | PubMed |
| 31388798 | Melatonin and Parkinson Disease: Current Status and Future Perspectives for Molecular Mechanisms. | Cell Mol Neurobiol | 2020 | https://conductscience.org/library/papers/31388798 | PubMed |
| 28221082 | Partial lesion of the nigrostriatal dopamine pathway in rats impairs egocentric learning but not spatial learning or behavioral flexibility. | Behav Neurosci | 2017 | https://conductscience.org/library/papers/28221082 | PubMed |
| 26704434 | Direct intranigral injection of dopaminochrome causes degeneration of dopamine neurons. | Neurosci Lett | 2016 | https://conductscience.org/library/papers/26704434 | PubMed |
| 26542636 | Combination of acamprosate and baclofen as a promising therapeutic approach for Parkinson's disease. | Sci Rep | 2015 | https://conductscience.org/library/papers/26542636 | PubMed |
| 24729952 | Abnormal Bursting as a Pathophysiological Mechanism in Parkinson's Disease. | Basal Ganglia | 2014 | https://conductscience.org/library/papers/24729952 | PubMed |
| 23940672 | Activation of GSK-3β and caspase-3 occurs in Nigral dopamine neurons during the development of apoptosis activated by a striatal injection of 6-hydroxydopamine. | PLoS One | 2013 | https://conductscience.org/library/papers/23940672 | PubMed |
| 23564299 | Neuroprotective effects of NMDA and group I metabotropic glutamate receptor antagonists against neurodegeneration induced by homocysteine in rat hippocampus: in vivo study. | J Mol Neurosci | 2013 | https://conductscience.org/library/papers/23564299 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TH | 7054 | PubTator's text mining | https://conductscience.org/library/genes/7054 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/11054705
GET https://conductscience.org/api/papers/v1/11054705/cited_by?page=2